| Title : NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment - Broggini_2016_Cancer.Lett_380_568 |
| Author(s) : Broggini T , Wustner M , Harms C , Stange L , Blaes J , Thome C , Harms U , Mueller S , Weiler M , Wick W , Vajkoczy P , Czabanka M |
| Ref : Cancer Letters , 380 :568 , 2016 |
| Abstract : Broggini_2016_Cancer.Lett_380_568 |
| ESTHER : Broggini_2016_Cancer.Lett_380_568 |
| PubMedSearch : Broggini_2016_Cancer.Lett_380_568 |
| PubMedID: 26297987 |
| Title : NDRG1 prognosticates the natural course of disease in WHO grade II glioma - Blaes_2014_J.Neurooncol_117_25 |
| Author(s) : Blaes J , Weiler M , Sahm F , Hentschel B , Osswald M , Czabanka M , Thome CM , Schliesser MG , Pusch S , Luger S , Winkler F , Radbruch A , Jugold M , Simon M , Steinbach JP , Schackert G , Tatagiba M , Westphal M , Tonn JC , Gramatzki D , Pietsch T , Hartmann C , Glimm H , Vajkoczy P , von Deimling A , Platten M , Weller M , Wick W |
| Ref : J Neurooncol , 117 :25 , 2014 |
| Abstract : Blaes_2014_J.Neurooncol_117_25 |
| ESTHER : Blaes_2014_J.Neurooncol_117_25 |
| PubMedSearch : Blaes_2014_J.Neurooncol_117_25 |
| PubMedID: 24395351 |
| Title : mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy - Weiler_2014_Proc.Natl.Acad.Sci.U.S.A_111_409 |
| Author(s) : Weiler M , Blaes J , Pusch S , Sahm F , Czabanka M , Luger S , Bunse L , Solecki G , Eichwald V , Jugold M , Hodecker S , Osswald M , Meisner C , Hielscher T , Rubmann P , Pfenning PN , Ronellenfitsch M , Kempf T , Schnolzer M , Abdollahi A , Lang F , Bendszus M , von Deimling A , Winkler F , Weller M , Vajkoczy P , Platten M , Wick W |
| Ref : Proc Natl Acad Sci U S A , 111 :409 , 2014 |
| Abstract : Weiler_2014_Proc.Natl.Acad.Sci.U.S.A_111_409 |
| ESTHER : Weiler_2014_Proc.Natl.Acad.Sci.U.S.A_111_409 |
| PubMedSearch : Weiler_2014_Proc.Natl.Acad.Sci.U.S.A_111_409 |
| PubMedID: 24367102 |